However, inconsistent findings from positive to negative or insignificant results were reported for the prognostic value of these biomarkers.13,21–24 In this study, we suggest additional findings for clinical impact of expression of CD8 and PD-L1 as prognostic biomarkers in NSCLC patients treated with surgical resection. Here, CD8A is linked to non-small cell lung carcinoma.